We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05239728
Brief Title: A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

First Submitted : February 4, 2022
First Submitted that Met QC Criteria : February 4, 2022
First Posted : February 15, 2022

Last Update Submitted that Met QC Criteria : January 19, 2023
Last Update Posted : January 20, 2023